Ask an expert

23 Mar 2007

Sudecks Atrophy
Hi there
My daugher aged 15 (a twin), has been suffering from Sudecks Atrophy since 2005, currently she is spending half the year at home. I've been to the Pain Clinic, she has had three temporary blocks, have been to doctors, specialists and she has had dopplers, MRI, X Rays, blood tests and once again she is at home and not able to fully walk on her left leg. Generally it starts in her hip, moves down to the knee and then ankle, leg becomes cold and swollen in the joints. I don't know what to do anymore and would appreciate some advice.
Thank you
Answer 859 views

01 Jan 0001

Dear Susan
See these articles:

Treatment includes tricyclic antidepressants, non steroidal anti-inflammatories (NSAIDs) and/or corticosteroids, Transcutaneous Electrical Nerve Stimulation (TENS) - you get a little machine for this.

Electro-acupuncture gave 70% improvement (G. S. E. Dowd, R. Hussein, V. Khanduja, and A. J. Ordman Complex regional pain syndrome with special emphasis on the knee J Bone Joint Surg Br, March 1, 2007; 89-B(3): 285 - 290. )

1: Clin Orthop Relat Res. 1987 Feb;(215):217-22. Links
Carbocalcitonin treatment in Sudeck's atrophy.Nuti R, Vattimo A, Martini G, Turchetti V, Righi GA.
The efficacy of new calcitonin, the amino analog of eel calcitonin (carboCT) on Sudeck's atrophy of the foot was investigated in 14 patients. CarboCT was administered at the dose of 40 Medical Research Council (MRC) units per day, and the duration of treatment was two to ten months. No adverse effects were noted. Bone pain and local edema decreased associated with improvement of motility. CarboCT induced a slight decrease in plasma calcium, plasma phosphate, and 24-hour urinary calcium excretion. An increase in cAMP/Cr ratio, an index of parathyroid function, was also observed (probably a manifestation of the hypocalcemic effect of calcitonin and secondary parathyroid stimulation). The whole body retention of 99mTc-MDP represents a valuable index of bone turnover, it decreased progressively and significantly on treatment. A dynamic study of local bone uptake of 99mTC-MDP was performed in eight patients. After carboCT therapy, statistically significant decreases in local blood flow, early uptake, and delayed uptake were appreciated in the involved foot. These findings lead to the conclusion that carboCT is effective in the treatment of Sudeck's atrophy.

Let me know if any of these make a difference! You will probably have to find a neurologist or orthopod willing to spend the time to experiment with different treatments.

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical examination, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.
Voting Booth
Have you entered our Health of the Nation survey?
Please select an option Oops! Something went wrong, please try again later.
32% - 9425 votes
68% - 19886 votes